MEREO BIOPHARMA - 53 Year Dividend History | MREO
Historical dividend payout and yield for MEREO BIOPHARMA (MREO) since 1971. The current TTM dividend payout for MEREO BIOPHARMA (MREO) as of April 26, 2024 is $0.00. The current dividend yield for MEREO BIOPHARMA as of April 26, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.342B |
$0.010B |
|
Mereo BioPharma Group PLC is a biopharmaceutical company. It is focused on development and commercialization of therapeutics for patients with rare diseases. The company's product pipeline includes BPS-804, MPH-966, BCT-197, BGS-649, Navicixizumab and Etigilimab which are in clinical stage. Mereo BioPharma Group PLC is based in London, United Kingdom.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
